ESP-INOCA: 疑われる心筋動脈不全と非阻害性冠動脈の患者の予後分層化のための国家マルチセンターレジストリの論理と設計
Eva Rumiz1, Fernando Rivero2, Ainhoa Pérez3
1Cardiology Department, Consorcio Hospital General Universitario, Universitat de València, Valencia, Spain; Cardiology Department, Hospital QuironSalud, Valencia, Spain.
International journal of cardiology
|August 31, 2025
まとめ
この研究では,閉塞性冠動脈疾患 (INOCA) がなく,不血症を患っている患者を対象としています. 全国規模のレジスタリを使用して,異なるINOCAエンドタイプの有病率と長期的な結果を決定することを目的としています.
科学分野:
- 心臓病科
- 血管医学
- 診断検査
背景:
- 閉塞性冠動脈疾患 (CAD) は,心筋不全の一般的な原因です.
- しかし,アンギナと発血不全の患者の最大50%は,冠動脈の不閉症 (INOCA) を有する.
- INOCAは異質で 診断も治療も不十分です
研究 の 目的:
- 異なるINOCAエンドタイプの流行を決定する.
- これらのINOCAエンドタイプの長期的な臨床結果を評価する.
- リスクの階層化とINOCAの理解を向上させる
主な方法:
- ESP-INOCA (前向きな,観察的な,縦断的な全国的な登録システム)
- 冠動脈血管図と冠動脈機能検査 (CFT) を受けている,心筋不全の疑いがある患者を含む.
- 内皮独立系血管機能の評価 (冠動脈フローリザーブ,マイクロ血管抵抗指数) と冠動脈血管運動障害 (アセチルコリン検査)
主要な成果:
- 慢性冠動脈症候群と心筋不全の疑いのある患者を登録した.
- 血管機能と血管運動障害を評価するために冠動脈機能検査を行った.
- 1年後の主要な心血管不良事件の複合体である.
結論:
- このレジストリーは,INOCAのエンドタイプの長期予測の洞察を提供します.
- INOCA患者に対するリスクの階層化を改善する.
- この異質な臨床実体に関する理解が深まる見込みである.
関連する概念動画
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:30Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30